These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18427982)

  • 1. The use of CDME in cystinosis research.
    Wilmer MJ; van den Heuvel LP; Levtchenko EN
    Neurochem Res; 2008 Nov; 33(11):2373-4. PubMed ID: 18427982
    [No Abstract]   [Full Text] [Related]  

  • 2. Cystine dimethylester model of cystinosis: still reliable?
    Wilmer MJ; Willems PH; Verkaart S; Visch HJ; de Graaf-Hess A; Blom HJ; Monnens LA; van den Heuvel LP; Levtchenko EN
    Pediatr Res; 2007 Aug; 62(2):151-5. PubMed ID: 17597653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteamine inhibition of [15N]-glycine turnover in cystinosis and of glycine cleavage system in vitro.
    Yudkoff M; Nissim I; Schneider A; Segal S
    Metabolism; 1981 Nov; 30(11):1096-103. PubMed ID: 7289883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cysteamine on amino acid pools of cultured fibroblasts and the uptake of L-proline.
    States B; Segal S
    Biochem Biophys Res Commun; 1982 Apr; 105(4):1327-32. PubMed ID: 7103957
    [No Abstract]   [Full Text] [Related]  

  • 5. Antioxidant effect of cysteamine in brain cortex of young rats.
    Kessler A; Biasibetti M; da Silva Melo DA; Wajner M; Dutra-Filho CS; de Souza Wyse AT; Wannmacher CM
    Neurochem Res; 2008 May; 33(5):737-44. PubMed ID: 17940891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of oxidative stress in kidney of rats loaded with cystine dimethyl ester.
    Rech VC; Feksa LR; Arevalo do Amaral MF; Koch GW; Wajner M; Dutra-Filho CS; Terezinha de Souza Wyse A; Duval Wannmacher CM
    Pediatr Nephrol; 2007 Aug; 22(8):1121-8. PubMed ID: 17534668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of cystine by cystine-depleted fibroblasts from patients with cystinosis.
    States B; Lee J; Segal S
    Biochem Biophys Res Commun; 1981 Jan; 98(1):290-6. PubMed ID: 7213388
    [No Abstract]   [Full Text] [Related]  

  • 8. Depletion of cystine in cystinotic fibroblasts by drugs enclosed in liposomes.
    Butler JD; Tietze F; Pellefigue F; Spielberg SP; Schulman JD
    Pediatr Res; 1978 Jan; 12(1):46-51. PubMed ID: 25405
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitochondrial Dynamics of Proximal Tubular Epithelial Cells in Nephropathic Cystinosis.
    De Rasmo D; Signorile A; De Leo E; Polishchuk EV; Ferretta A; Raso R; Russo S; Polishchuk R; Emma F; Bellomo F
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31888107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteamine restores glutathione redox status in cultured cystinotic proximal tubular epithelial cells.
    Wilmer MJ; Kluijtmans LA; van der Velden TJ; Willems PH; Scheffer PG; Masereeuw R; Monnens LA; van den Heuvel LP; Levtchenko EN
    Biochim Biophys Acta; 2011 Jun; 1812(6):643-51. PubMed ID: 21371554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of carbohydrate-cysteamine thiazolidines as pro-drugs for the treatment of cystinosis.
    Ramazani Y; Levtchenko EN; Van Den Heuvel L; Van Schepdael A; Paul P; Ivanova EA; Pastore A; Hartman TM; Price NPJ
    Carbohydr Res; 2017 Feb; 439():9-15. PubMed ID: 28033491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of pantethine in cystinosis.
    Wittwer CT; Gahl WA; Butler JD; Zatz M; Thoene JG
    J Clin Invest; 1985 Oct; 76(4):1665-72. PubMed ID: 4056044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis.
    Levtchenko EN; van Dael CM; de Graaf-Hess AC; Wilmer MJ; van den Heuvel LP; Monnens LA; Blom HJ
    Pediatr Nephrol; 2006 Jan; 21(1):110-3. PubMed ID: 16252107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the treatment of cystinosis.
    Schneider JA; Clark KF; Greene AA; Reisch JS; Markello TC; Gahl WA; Thoene JG; Noonan PK; Berry KA
    J Inherit Metab Dis; 1995; 18(4):387-97. PubMed ID: 7494398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of cystine in cystinotic fibroblasts by homocysteine. Synergism of cysteamine with various reducing agents in depletion of cystine from cystinotic fibroblasts.
    Butler JD
    Biochem Pharmacol; 1990 Aug; 40(4):879-85. PubMed ID: 2386552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Handling of L-[35S]cystine by cysteamine-pretreated cystinotic and normal fibroblasts.
    States B; Lee J; Segal S
    Arch Biochem Biophys; 1983 Feb; 220(2):361-9. PubMed ID: 6824329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenchymal organ cystine depletion with long-term cysteamine therapy.
    Gahl WA; Charnas L; Markello TC; Bernardini I; Ishak KG; Dalakas MC
    Biochem Med Metab Biol; 1992 Dec; 48(3):275-85. PubMed ID: 1476793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteamine prevents inhibition of thiol-containing enzymes caused by cystine or cystine dimethylester loading in rat brain cortex.
    Rech VC; Feksa LR; Fleck RM; Athaydes GA; Dornelles PK; Rodrigues-Junior V; Wannmacher CM
    Metab Brain Dis; 2008 Jun; 23(2):133-45. PubMed ID: 18418703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteamine prevents and reverses the inhibition of pyruvate kinase activity caused by cystine in rat heart.
    Rosa TG; de Souza Wyse AT; Wajner M; Wannmacher CM
    Biochim Biophys Acta; 2004 Jun; 1689(2):114-9. PubMed ID: 15196592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Cysteamine Delivery Nanowafer as an Efficacious Treatment Modality for Corneal Cystinosis.
    Marcano DC; Shin CS; Lee B; Isenhart LC; Liu X; Li F; Jester JV; Pflugfelder SC; Simpson J; Acharya G
    Mol Pharm; 2016 Oct; 13(10):3468-3477. PubMed ID: 27571217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.